TECX Tectonic Therapeutic, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 6, 2026
$22,54
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$14,60rendah 52m
$39,53tinggi 52m
Kapitalisasi Pasar (MRQ)
$434M
P/E
-5.6
EPS
$-4.05
lencana Anda
Rentang 52M
$15–$40
Peringkat Analis
BUY
Target Harga
$77
P/E
-5.6
ROE
-27.7%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
TECX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$22.54
Kapitalisasi Pasar (MRQ)
$434M
P/E
-5.6
EPS
$-4.05
ROE
-27.7%
Rentang 52M
$15–$40
TECX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 21 Juni 2024 | 1-for-12 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-4.052021-12-31 → 2025-12-31
Arus Kas Bebas$-60M2018-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | TECX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -5.6rata-rata 5T ≈-6.5 | ≈-6.5 | · | · | |
| P/B (MRQ) | 1.9rata-rata 5T ≈6.1 | ≈6.1 | 3.0 | Nilai wajar | |
| Harga / FCF (TTM) | -6.0rata-rata 5T ≈-10.5 | ≈-10.5 | · | · | |
| Harga / Arus Kas (TTM) | -6.0rata-rata 5T ≈-10.6 | ≈-10.6 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 1.7rata-rata 5T ≈5.9 | ≈5.9 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | TECX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -35.8%rata-rata 5T ≈-40.6% | ≈-40.6% | -42.2% | Tingkat teratas | |
| ROE | -27.7%rata-rata 5T ≈-18.5% | ≈-18.5% | -78.7% | Tingkat teratas | |
| ROIC | -34.0% | · | -67.4% | Tingkat teratas |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | TECX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 22.3rata-rata 5T ≈14.6 | ≈14.6 | 5.1 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 26.3rata-rata 5T ≈14.1 | ≈14.1 | 2.9 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
4.4%
Laporan Berikutnya
Nov 04, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 19, 2026 | $-1.18 | $-1.38 | 14.6% |
| 31 Maret 2026 | $-1.34 | $-1.21 | -11.1% | |
| 31 Des. 2025 | $-1.03 | $-1.13 | 8.5% | |
| 30 Sep. 2025 | $-1.02 | $-1.07 | 4.5% | |
| 30 Juni 2025 | $-1.07 | $-1.00 | -6.9% | |
| 31 Maret 2025 | $-0.93 | $-1.11 | 16.5% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $63M | $41M | $37M | $72M | $83M | $87M | $55M | $35M | $15M | |
| SG&A Expense | $21M | $17M | $8M | $33M | $36M | $33M | $21M | $11M | $3M | |
| Operating Expenses | $84M | $58M | $45M | $105M | $119M | $120M | $76M | $46M | $18M | |
| Operating Income | $-84M | $-58M | $-45M | $-105M | $-119M | $-120M | $-76M | $-46M | $-18M | |
| Interest Income | $11M | $4M | $581.0K | · | · | $719.0K | $3M | $2M | $57.0K | |
| Other Non-op | $-119.0K | $-511.0K | $396.0K | $-456.0K | $-285.0K | $516.0K | $3M | $-118.0K | $-262.0K | |
| Pretax Income | $-73M | $-58M | · | · | · | · | · | · | · | |
| Income Tax | $1M | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-74M | $-58M | $-43M | $-106M | $-119M | $-120M | $-73M | $-46M | $-19M | |
| EPS (Basic) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | · | · | · | · | |
| EPS (Diluted) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | · | · | · | · | |
| Shares (Basic) | 18,322,533 | 8,490,171 | 1,268,512 | 43,739,000 | 42,854 | · | · | · | · | |
| Shares (Diluted) | 18,322,533 | 8,490,171 | 1,268,512 | 43,739,000 | 42,854 | · | · | · | · | |
| EBITDA | $-83M | $-56M | $11M | $-104M | $-117M | $-119M | $-75M | $-46M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $254M | $141M | $29M | $93M | $190M | $260M | $187M | $126M | $6M | |
| Prepaid Expense | $3M | $6M | $2M | $7M | $10M | $8M | $9M | $4M | $345.0K | |
| Other Current Assets | · | · | $570.0K | $1M | $2M | $271.0K | $344.0K | $795.0K | $60.0K | |
| Current Assets | $257M | $147M | $31M | $100M | $199M | $267M | $196M | $130M | $6M | |
| PP&E (Net) | $1M | $2M | $3M | $3M | $4M | $3M | $4M | $3M | $349.0K | |
| PP&E (Gross) | $5M | $5M | $5M | $7M | $8M | $5M | $5M | $3M | $394.0K | |
| Accum. Depreciation | $3M | $3M | $2M | $4M | $4M | $2M | $1M | $384.0K | $45.0K | |
| Other Non-current Assets | $640.0K | $156.0K | $31.0K | $40.0K | $74.0K | $436.0K | $625.0K | $825.0K | $365.0K | |
| Total Assets | $261M | $153M | $39M | $104M | $204M | $271M | $201M | $133M | $7M | |
| Accounts Payable | $1M | $976.0K | $409.0K | $384.0K | $3M | $3M | $4M | $3M | $527.0K | |
| Accrued Liabilities | $7M | $8M | $8M | $12M | $16M | $14M | $10M | $8M | $2M | |
| Current Liabilities | $10M | $12M | $41M | $13M | $19M | $17M | $14M | $11M | $3M | |
| Capital Leases | $0 | $132.0K | $2M | $188.0K | $0 | · | · | · | · | |
| Deferred Tax | · | · | $0 | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | $500.0K | |
| Total Liabilities | $10M | $12M | $43M | $29M | $34M | $17M | $15M | $11M | $4M | |
| Long-term Debt | · | · | · | $15M | $15M | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $0 | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | · | |
| Paid-in Capital | $474M | $289M | $6M | · | · | · | · | · | · | |
| Retained Earnings | $-223M | $-149M | $-91M | $-489M | $-384M | $-264M | $-145M | $-72M | $-23M | |
| AOCI | $-96.0K | $9.0K | $-11.0K | · | · | · | · | · | · | |
| Stockholders' Equity | $251M | $141M | $-85M | $-46M | $169M | $254M | $186M | $122M | $-23M | |
| Liabilities + Equity | $261M | $153M | $39M | $104M | $204M | $271M | $201M | $133M | $7M | |
| Shares Outstanding | 18,738,249 | 14,856,309 | 1,407,753 | 43,916,000 | 43,652,000 | 43,652,000 | 31,643,000 | 23,806,628 | 2,305,173 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $2M | $1M | $1M | $1M | $1M | $850.0K | $380.0K | $45.0K | |
| Stock-based Comp | $10M | $3M | $1M | $12M | $19M | $16M | $7M | $2M | $177.0K | |
| Deferred Tax | $19M | $17M | $15M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-16M | $-23M | $-83M | $-4M | $1M | $4M | $-2M | $6M | · | |
| Operating Cash Flow | $-60M | $-59M | $-41M | $-97M | $-98M | $-99M | $-68M | $-38M | $-16M | |
| CapEx | $208.0K | $156.0K | $279.0K | $267.0K | $2M | $1M | $2M | $2M | $383.0K | |
| Investing Cash Flow | $-138.0K | $-156.0K | $-279.0K | $-267.0K | $-2M | $-1M | $-2M | $-2M | $-383.0K | |
| Debt Issued | · | · | · | $0 | $15M | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $15M | · | · | · | · | |
| Stock Issued | · | · | $86.0K | $204.0K | · | · | $129M | $104M | · | |
| Net Stock Activity | · | · | $86.0K | · | · | · | $129M | · | · | |
| Financing Cash Flow | $173M | $172M | $34M | $262.0K | $30M | $173M | $130M | $160M | $17M | |
| Net Change in Cash | $113M | $112M | $-7M | $-97M | $-70M | $73M | $61M | $121M | $606.0K | |
| Taxes Paid | $1M | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-60M | $-59M | $-63M | $-97M | $-100M | $-100M | $-69M | $-39M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -35.8% | -60.3% | 11.9% | -68.8% | -50.1% | -50.7% | -43.7% | -66.0% | · | |
| ROE | -27.7% | -39.8% | 162.5% | -122.1% | -65.6% | -51.8% | -37.1% | -35.8% | · | |
| ROIC | -34.0% | · | · | · | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.6 | 12.6 | 15.8 | 7.6 | 10.3 | 16.1 | 14.0 | 12.3 | · | |
| Quick Ratio | 26.3 | 12.2 | 15.4 | 7.1 | 9.8 | 15.6 | 13.3 | 11.9 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.41 | $9.48 | $2.12 | $1.72 | $4.08 | $6.12 | $5.88 | $5.13 | · | |
| Cash Flow / Share | $-3.28 | $-6.96 | $-1.42 | $-2222.46 | · | · | · | · | · | |
| Cash / Share | $13.54 | $9.51 | $2.20 | $2.11 | $4.56 | $6.25 | $5.91 | $5.31 | · | |
| Dividend / Share | $0.00 | $0.00 | · | · | · | · | · | · | · | |
| EPS (TTM) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-74M | $-58M | $-43M | $-106M | $-119M | $-120M | $-73M | $-46M | · | |
| Market Cap | $391M | $686M | $729M | $374M | $1.92B | $6.95B | $7.64B | $4.76B | · | |
| P/E | -5.2 | -6.8 | -0.5 | -3.5 | -16.6 | · | · | · | · | |
| P/B | 1.6 | 4.9 | 7.7 | 5.0 | 11.3 | 27.3 | 41.1 | 38.9 | · | |
| P / Tangible Book | 1.6 | 4.9 | · | · | 11.3 | 27.3 | · | · | · | |
| P / Cash Flow | -6.5 | -11.6 | -11.5 | -3.8 | -19.6 | -70.4 | -113.0 | -126.3 | · | |
| P / FCF | -6.5 | -11.6 | -11.5 | -3.8 | -19.1 | -69.6 | -110.4 | -120.5 | · | |
| Earnings Yield | -19.4% | -14.8% | -206.9% | -28.4% | -6.0% | · | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $18M | $21M | $16M | $17M | $17M | $13M | $9M | $14M | $7M | $11M | $3M | $8M | $9M | $17M | $18M | $16M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $2M | $-11M | $6M | $5M | $8M | $7M | $7M | |
| Operating Expenses | $24M | $27M | $22M | $22M | $22M | $18M | $14M | $20M | $11M | $13M | $-1M | $10M | $11M | $25M | $25M | $23M | |
| Operating Income | $-24M | $-27M | $-22M | $-22M | $-22M | $-18M | $-14M | $-20M | $-11M | $-13M | $1M | $-10M | $-11M | $-25M | $-25M | $-23M | |
| Interest Income | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $318.0K | $256.0K | $133.0K | $97.0K | $224.0K | · | · | · | |
| Other Non-op | $-5.0K | $-113.0K | $-8.0K | $-31.0K | $-48.0K | $-32.0K | $-96.0K | $-7.0K | $-5.0K | $-403.0K | $390.0K | $-1.0K | $-8.0K | $15.0K | $-321.0K | $-95.0K | |
| Pretax Income | $-22M | · | $-19M | $-19M | $-19M | · | $-12M | $-18M | $-13M | · | · | · | · | · | · | · | |
| Income Tax | $77.0K | · | $254.0K | $0 | $976.0K | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | |
| Net Income | $-22M | $-25M | $-19M | $-19M | $-20M | $-16M | $-12M | $-18M | $-13M | $-15M | $-8M | $-10M | $-10M | $-14M | $-25M | $-23M | |
| EPS (Basic) | $-1.18 | $-1.34 | $-1.03 | $-1.02 | $-1.07 | $-0.93 | $9.68 | $-1.20 | $-4.34 | $-10.97 | $-17.06 | $-7.62 | $-8.51 | $-0.57 | $-0.58 | $-0.52 | |
| EPS (Diluted) | $-1.18 | $-1.34 | $-1.03 | $-1.02 | $-1.07 | $-0.93 | $9.68 | $-1.20 | $-4.34 | $-10.97 | $-17.06 | $-7.62 | $-8.51 | $-0.57 | $-0.58 | $-0.52 | |
| Shares (Basic) | 18,964,008 | 18,769,004 | · | 18,712,767 | 18,680,042 | 17,157,661 | · | 14,729,018 | 2,919,872 | 1,387,303 | · | 1,319,147 | 1,228,778 | 44,037,000 | · | 43,773,000 | |
| Shares (Diluted) | 18,964,008 | 18,769,004 | · | 18,712,767 | 18,680,042 | 17,157,661 | · | 14,729,018 | 2,919,872 | 1,387,303 | · | 1,319,147 | 1,228,778 | 44,037,000 | · | 43,773,000 | |
| EBITDA | $-24M | $-27M | · | $-22M | $-22M | $-18M | · | $-20M | $-11M | $-8M | · | $-23M | $68M | $-25M | · | $-23M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $227M | $237M | $254M | $268M | $287M | $306M | $141M | $159M | $185M | $90M | $29M | $106M | $125M | $72M | $93M | $116M | |
| Prepaid Expense | $4M | $3M | $3M | $4M | $3M | $3M | $6M | $4M | $2M | $1M | $2M | $3M | $4M | $5M | $7M | $10M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $626.0K | · | $805.0K | $792.0K | $845.0K | $1M | $765.0K | |
| Current Assets | $231M | $240M | $257M | $273M | $291M | $310M | $147M | $163M | $187M | $92M | $31M | $109M | $129M | $77M | $100M | $126M | |
| PP&E (Net) | $858.0K | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | · | $3M | $0 | $2M | $3M | $3M | $3M | |
| PP&E (Gross) | · | · | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | · | · | $3M | $3M | $3M | $3M | $3M | $3M | $2M | · | $2M | $4M | $4M | $4M | $4M | $3M | |
| Other Non-current Assets | $626.0K | $663.0K | $640.0K | $597.0K | $287.0K | $138.0K | $156.0K | $190.0K | $13.0K | · | $31.0K | $40.0K | $40.0K | $40.0K | $40.0K | $41.0K | |
| Total Assets | $237M | $247M | $261M | $277M | $295M | $315M | $153M | $169M | $194M | $92M | $39M | $111M | $134M | $83M | $104M | $129M | |
| Accounts Payable | $2M | $3M | $1M | $1M | $3M | $6M | $976.0K | $3M | $4M | $243.0K | $409.0K | $910.0K | $1M | $591.0K | $384.0K | $2M | |
| Accrued Liabilities | $7M | $9M | $7M | $7M | $7M | $5M | $8M | $13M | $20M | $3M | $8M | $5M | $8M | $11M | $12M | $14M | |
| Current Liabilities | $10M | $13M | $10M | $9M | $11M | $14M | $12M | $17M | $26M | $4M | $41M | $8M | $12M | $14M | $13M | $16M | |
| Capital Leases | $3M | $3M | $0 | $0 | $0 | $0 | $132.0K | $523.0K | $905.0K | · | $2M | $105.0K | $134.0K | $352.0K | $188.0K | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Total Liabilities | $13M | $16M | $10M | $9M | $12M | $14M | $12M | $18M | $28M | $4M | $43M | $8M | $12M | $30M | $29M | $31M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $15M | · | $15M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $4.0K | $0 | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $494M | $478M | $474M | $471M | $468M | $466M | $289M | $287M | $285M | · | $6M | · | · | · | · | · | |
| Retained Earnings | $-270M | $-248M | $-223M | $-204M | $-184M | $-164M | $-149M | $-136M | $-118M | $-484M | $-91M | $-468M | $-447M | $-514M | $-489M | $-464M | |
| AOCI | $0 | $0 | $-96.0K | $-75.0K | $-49.0K | $2.0K | $9.0K | $-77.0K | $-61.0K | · | $-11.0K | · | · | · | · | · | |
| Stockholders' Equity | $224M | $230M | $251M | $268M | $284M | $301M | $141M | $150M | $166M | $89M | $-85M | $103M | $122M | $53M | $75M | $98M | |
| Liabilities + Equity | $237M | $247M | $261M | $277M | $295M | $315M | $153M | $169M | $194M | $92M | $39M | $111M | $134M | $83M | $104M | $129M | |
| Shares Outstanding | 19,235,221 | 18,830,436 | 18,738,249 | 18,713,223 | 18,712,138 | 18,671,229 | 14,856,309 | 14,744,477 | 14,734,323 | 44,882,000 | 1,407,753 | 44,558,000 | 44,308,000 | 44,088,000 | 43,916,000 | 43,773,000 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $285.0K | $304.0K | $333.0K | $342.0K | $340.0K | $360.0K | $508.0K | $424.0K | $713.0K | $377.0K | $373.0K | $488.0K | $289.0K | $328.0K | $351.0K | $336.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $2M | $-154.0K | $321.0K | $294.0K | $-3M | $-2M | $3M | $2M | $3M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Other Non-cash | · | $3M | · | · | · | $360.0K | · | · | · | $-2M | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-21M | $-18M | $-14M | $-18M | $-15M | $-13M | $-17M | $-20M | $-15M | $-9M | $-12M | $6M | $-259.0K | $-20M | $-24M | $-16M | |
| CapEx | $79.0K | $19.0K | $0 | $181.0K | $0 | $27.0K | $3.0K | $153.0K | $0 | $4.0K | $50.0K | $221.0K | $214.0K | $8.0K | $0 | $86.0K | |
| Investing Cash Flow | $-59.0K | $-19.0K | $0 | $-166.0K | $55.0K | $-27.0K | $-3.0K | $-153.0K | $0 | $-4.0K | $-50.0K | $-84M | $-214.0K | $-8.0K | $0 | $-86.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $4.0K | · | $73.0K | $0 | $13.0K | $1.0K | $203.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $4.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $12M | $847.0K | $-141.0K | $-457.0K | $-4M | $178M | $-1M | $-6M | $179M | $-668.0K | $34M | $16M | $-324.0K | $55.0K | $59.0K | $60.0K | |
| Net Change in Cash | $-10M | $-17M | $-15M | $-18M | $-19M | $165M | $-18M | $-26M | $164M | $-10M | $22M | $-62M | $-797.0K | $-20M | $-24M | $-16M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-8M | · | · | · | $-20M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -8.4% | -9.0% | · | -8.5% | -8.2% | -7.8% | · | -12.7% | -7.7% | -7.8% | · | -18.0% | 48.2% | -19.3% | · | -13.3% | |
| ROE | -8.8% | -9.5% | · | -9.1% | -8.9% | -8.2% | · | -14.0% | -8.8% | -9.6% | · | -21.5% | 56.1% | -25.4% | · | -15.8% | |
| ROIC | -10.9% | · | · | -8.2% | -8.3% | · | · | · | · | · | · | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.3 | 18.5 | · | 29.2 | 25.6 | 22.9 | · | 9.4 | 7.2 | 26.2 | · | 14.4 | 11.0 | 5.4 | · | 7.8 | |
| Quick Ratio | 21.9 | 18.3 | · | 28.6 | 25.3 | 22.7 | · | 9.2 | 7.1 | 25.8 | · | 14.0 | 10.7 | 5.1 | · | 7.2 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $11.64 | $12.24 | · | $14.30 | $15.16 | $16.12 | · | $10.20 | $11.29 | $1.98 | · | $2.31 | $2.75 | $1.20 | · | $2.24 | |
| Cash Flow / Share | · | $-0.98 | · | · | · | $-0.76 | · | · | · | $-0.17 | · | · | · | $-460.61 | · | · | |
| Cash / Share | $11.80 | $12.58 | · | $14.34 | $15.36 | $16.40 | · | $10.79 | $12.56 | $2.02 | · | $2.38 | $2.81 | $1.64 | · | $2.65 | |
| Dividend / Share | · | · | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-4.57 | $-4.46 | · | $6.66 | $6.48 | $3.21 | · | $-33.57 | $-39.99 | $-44.16 | · | $-17.28 | $-10.18 | $-2.31 | · | $-2.49 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-86M | $-83M | · | $-67M | $-66M | $-59M | · | $-53M | $-46M | $-44M | · | $-60M | $-73M | $-91M | · | $-109M | |
| Market Cap | $661M | $582M | · | $294M | $372M | $331M | · | $447M | $243M | $689M | · | $823M | $505M | $529M | · | $336M | |
| P/E | -7.5 | -6.9 | · | 2.4 | 3.1 | 5.5 | · | -0.9 | -0.4 | -0.3 | · | -1.1 | -1.1 | -5.2 | · | -3.1 | |
| P/B | 3.0 | 2.5 | · | 1.1 | 1.3 | 1.1 | · | 3.0 | 1.5 | 7.8 | · | 8.0 | 4.1 | 10.0 | · | 3.4 | |
| P / Tangible Book | 3.0 | 2.5 | · | 1.1 | 1.3 | 1.1 | · | 3.0 | 1.5 | 7.8 | · | 8.0 | 4.1 | 10.0 | · | 3.4 | |
| P / Cash Flow | · | -31.6 | · | · | · | -25.3 | · | · | · | -91.1 | · | · | · | -26.1 | · | · | |
| Earnings Yield | -13.3% | -14.4% | · | 42.4% | 32.6% | 18.1% | · | -110.8% | -242.8% | -287.5% | · | -93.5% | -89.3% | -19.2% | · | -32.4% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-74M | $-58M | $-43M | $-106M | $-119M |
| EPS Dilusian | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 26.6 | 12.6 | 15.8 | 7.6 | 10.3 |
| Rasio Cepat | 26.3 | 12.2 | 15.4 | 7.1 | 9.8 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-60M | $-59M | $-63M | $-97M | $-100M |
Pemilik institusional (13F) 132 pengaju · $487.9M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
132
Nilai yang dipegang
$487.9M
Posisi baru
26
Posisi yang keluar
10
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 26 (-3 vs Kuartal sebelumnya) | 10 (-8 vs Kuartal sebelumnya) | 39 (+3 vs Kuartal sebelumnya) | 41 (+4 vs Kuartal sebelumnya) | +85K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $97.294.233 | 2.830.378 | 19,94% | Saham |
| TCG Crossover Management, LLC | $41.418.128 | 1.204.891 | 8,49% | Saham |
| Aberdeen Group plc | $39.250.200 | 1.141.824 | 8,04% | Saham |
| BlackRock, Inc. | $29.651.600 | 862.592 | 6,08% | Saham |
| First Light Asset Management, LLC | $27.524.958 | 800.726 | 5,64% | Saham |
| BAKER BROS. ADVISORS LP | $20.892.713 | 607.788 | 4,28% | Saham |
| 5AM Venture Management, LLC | $20.853.938 | 606.660 | 4,27% | Saham |
| BRAIDWELL LP | $20.518.438 | 596.900 | 4,21% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.802.672 | 488.805 | 3,44% | Saham |
| Vestal Point Capital, LP | $14.609.375 | 425.000 | 2,99% | Saham |
| VANGUARD GROUP INC | $12.513.872 | 599.898 | 2,56% | Saham |
| KENNEDY CAPITAL MANAGEMENT LLC | $9.700.694 | 282.202 | 1,99% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $9.299.108 | 270.461 | 1,91% | Saham |
| ORBIMED ADVISORS LLC | $7.789.375 | 226.600 | 1,60% | Saham |
| STATE STREET CORP | $7.559.338 | 219.908 | 1,55% | Saham |
| Ikarian Capital, LLC | $7.075.647 | 205.837 | 1,45% | Saham |
| D. E. Shaw & Co., Inc. | $6.412.656 | 186.550 | 1,31% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.054.318 | 176.100 | 1,24% | Opsi beli |
| MARSHALL WACE, LLP | $5.916.833 | 172.101 | 1,21% | Saham |
| MILLENNIUM MANAGEMENT LLC | $5.689.922 | 165.525 | 1,17% | Saham |
| Squarepoint Ops LLC | $4.985.338 | 145.028 | 1,02% | Saham |
| AMERIPRISE FINANCIAL INC | $4.896.673 | 142.448 | 1,00% | Saham |
| WELLS FARGO & COMPANY/MN | $4.036.588 | 117.428 | 0,83% | Saham |
| NORTHERN TRUST CORP | $3.915.450 | 113.904 | 0,80% | Saham |
| Soleus Capital Management, L.P. | $3.495.388 | 101.684 | 0,72% | Saham |
| Woodline Partners LP | $3.437.500 | 100.000 | 0,70% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.245.481 | 94.414 | 0,67% | Saham |
| CITADEL ADVISORS LLC | $3.107.260 | 90.393 | 0,64% | Saham |
| GOLDMAN SACHS GROUP INC | $2.541.138 | 73.924 | 0,52% | Saham |
| RAYMOND JAMES FINANCIAL INC | $2.498.169 | 72.674 | 0,51% | Saham |
| SECTORAL ASSET MANAGEMENT INC | $2.440.934 | 71.009 | 0,50% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $2.351.044 | 68.394 | 0,48% | Saham |
| JANE STREET GROUP, LLC | $2.262.596 | 65.821 | 0,46% | Saham |
| MORGAN STANLEY | $2.247.205 | 65.373 | 0,46% | Saham |
| Connor, Clark & Lunn Investment Management Ltd. | $2.232.313 | 64.940 | 0,46% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.089.003 | 60.771 | 0,43% | Saham |
| JPMORGAN CHASE & CO | $1.831.995 | 55.364 | 0,38% | Saham |
| KOTLER KEVIN | $1.668.800 | 80.000 | 0,34% | Saham |
| Tetragon Partners GP Ltd | $1.598.988 | 46.516 | 0,33% | Saham |
| PFM Health Sciences, LP | $1.568.566 | 45.631 | 0,32% | Saham |
| Jump Financial, LLC | $1.491.875 | 43.400 | 0,31% | Saham |
| Prosight Management, LP | $1.365.753 | 39.731 | 0,28% | Saham |
| Trexquant Investment LP | $1.271.566 | 36.991 | 0,26% | Saham |
| Aldebaran Capital, LLC | $1.264.897 | 36.797 | 0,26% | Saham |
| ExodusPoint Capital Management, LP | $1.211.341 | 35.239 | 0,25% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $1.080.475 | 31.432 | 0,22% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.046.306 | 30.438 | 0,21% | Saham |
| MONIMUS CAPITAL MANAGEMENT, LP | $967.416 | 28.143 | 0,20% | Saham |
| Bank of New York Mellon Corp | $867.872 | 25.247 | 0,18% | Saham |
| ALPS ADVISORS INC | $658.178 | 19.147 | 0,13% | Saham |
Aktivis & pemilik 5%+ 6 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Timothy A. Springer, TAS Partners LLC, Chafen Lu ×5 pengajuan | 7 April 2025 | 31,50% | Amandemen | · | SEC |
| Terrance McGuire, Polaris Partners IX, L.P., Polaris Partners GP IX, L.L.C., Polaris Founders Capital Fund I, L.P., Polaris Founders Capital Fund Management Co. I, L.L.C., Polaris Founders Capital Fund II, L.P., Polaris Founders Capital Fund Management Co. II, L.L.C., Jonathan Flint ×3 pengajuan | 7 April 2025 | 6,30% | Amandemen | · | SEC |
| Vida Ventures II, LLC, Vida Ventures II-A, LLC, VV Manager II, LLC ×3 pengajuan | 7 April 2025 | 0,00% | Amandemen | · | SEC |
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×2 pengajuan | 28 Okt. 2024 | · | Pengajuan awal | · | SEC |
| SVLSF VI, LLC, SV Life Sciences Fund VI, L.P., SV Life Sciences Fund VI Strategic Partners, L.P., SV Life Sciences Fund VI (GP), L.P. ×2 pengajuan | 16 Feb. 2021 | · | Pengajuan awal | · | SEC |
| Clarus Lifesciences III, L.P., Clarus Ventures III GP, L.P., Blackstone Clarus III L.L.C., Blackstone Holdings II L.P., Blackstone Holdings I/II GP L.L.C., The Blackstone Group Inc., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×4 pengajuan | 6 Agu 2019 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 33 orang dalam · 17 pejabat · 15 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Alise Reicin | Chief Executive Officer | 25 Sep. 2026 F | 309.078 | 2 | 0 | $105.500 |
| Erik Ostrowski | Interim CEO, President and CFO | 1 Feb. 2024 M | 29.285 | 0 | 0 | $0 |
| Geoffrey Mackay | President & CEO | 8 Feb. 2023 A | 188.012 | 0 | 0 | $0 |
| Daniel Lochner | Chief Financial Officer | 25 Sep. 2026 F | 58.024 | 1 | 0 | $129.660 |
| Katina Dorton | Chief Financial Officer | 8 Okt. 2018 M | 10.000 | 0 | 0 | $0 |
| Birgitte Volck | President of R&D | 4 Maret 2020 A | · | 0 | 0 | $0 |
| Christian Cortis | Chief Operating Officer | 20 Juni 2024 A | 126.368 | 0 | 0 | $0 |
| Peter Mcnamara | Chief Scientific Officer | 30 Sep. 2026 S | 54.305 | 0 | 8 | $-288.006 |
| Marcella K. Ruddy | Chief Medical Officer | 25 Sep. 2026 F | 67.157 | 0 | 3 | $-363.000 |
| Marc Schwabish | Chief Business Officer | 25 Sep. 2026 F | 44.903 | 0 | 0 | $0 |
| Azadeh Golipour | Chief Technology Officer | 1 Feb. 2024 M | 55.872 | 0 | 0 | $0 |
| Essra Ridha | Chief Medical Officer | 1 Feb. 2024 M | 15.881 | 0 | 0 | $0 |
| Steven Avruch | Chief Legal Officer | 1 Feb. 2024 M | 22.022 | 0 | 0 | $0 |
| Deanna M Petersen | Chief Business Officer | 8 Feb. 2023 A | · | 0 | 0 | $0 |
| Christopher Mason | Chief Scientific Officer | 10 Juni 2021 A | · | 0 | 0 | $0 |
| Diana Escolar | Chief Medical Officer | 10 Juni 2021 A | · | 0 | 0 | $0 |
| Nerissa Kreher | Chief Medical Officer | 8 Okt. 2018 M | 2.942 | 0 | 0 | $0 |
| Stefan Vitorovic | Direktur | 9 Juni 2026 A | 27.774 | 0 | 0 | $0 |
| Praveen P. Tipirneni | Direktur | 9 Juni 2026 A | 3.037 | 0 | 0 | $0 |
| Phillip B. Donenberg | Direktur | 9 Juni 2026 A | 2.000 | 0 | 0 | $0 |
| Timothy A. Springer | Direktur | 9 Juni 2026 A | 1.503.358 | 0 | 0 | $0 |
| Jessica Caroline Chutter | Direktur | 8 Juni 2026 A | · | 0 | 0 | $0 |
| Terrance McGuire | Direktur | 9 Juni 2025 A | 573.062 | 0 | 0 | $0 |
| Christopher Paige | Direktur | 6 Juni 2023 A | 252.512 | 0 | 0 | $0 |
| Annalisa Jenkins | Direktur | 6 Juni 2023 A | · | 0 | 0 | $0 |
| Philip J. Vickers | Direktur | 6 Juni 2023 A | 4.800 | 0 | 0 | $0 |
| Gail M Farfel | Direktur | 6 Juni 2023 A | · | 0 | 0 | $0 |
| Bruce Booth | Direktur | 6 Juni 2023 A | 5.567.289 | 0 | 0 | $0 |
| Ian T Clark | Direktur | 6 Juni 2023 A | · | 0 | 0 | $0 |
| Scott Requadt | Direktur | 25 Juni 2018 C | 2.962.325 | 0 | 0 | $0 |
| ATLAS VENTURE ASSOCIATES X, L.P. | Pemilik 10% | 13 Feb. 2020 J | 3.710.052 | 0 | 0 | $0 |
| Francois Nader | · | 1 April 2026 A | · | 0 | 0 | $0 |
| Leonard Braden Michael | · | 20 Juni 2024 J | 33.333 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 20 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,62% | 10.265 NS | 31 Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,07% | 34.693 SH | 11 Sep. 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 1.339 SH | 2 Okt. 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 7.356 SH | 19 Agu 2026 | Harian |
| IBB · iShares Trust | 0,02% | 70.963 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 58.897 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,01% | 264.002 SH | 11 Sep. 2026 | Harian |
| RSSL · Global X Funds | 0,01% | 4.882 NS | 31 Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 19.539 SH | 11 Sep. 2026 | Harian |
| DXUV · Dimensional ETF Trust | 0,00% | 371 NS | 31 Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 7.996 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 5.450 SH | 3 Sep. 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,00% | 975 NS | 31 Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1.127 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 111.919 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 364.413 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.713 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.002 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,00% | 25.446 SH | 19 Agu 2026 | Harian |
| IWN · iShares Trust | · | 77.593 SH | 11 Sep. 2026 | Harian |
TECX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 16 analis
BELI
Target median
$78.00
+246,1%
6 37,5%
Beli Kuat
9 56,2%
Beli
1 6,2%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
8 analis · 2026-10-03Target rata-rata $76.62 +240,0%
← Di bawah semua target
Harga saat ini $22.54
Rendah$60.00
Rata-rata$76.62
Tinggi$93.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| DMAC | $428M | · | · | · | -78.7% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | · |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | · |
| EIKN | · | · | · | · | · | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 6, 2026